Paclitaxel in combination with AT-101 induces apoptosis via supressing Bcl-2, bcl-XL, mcl-1 proteins in human breast cancer cells.

dc.contributor.authorCakar, B
dc.contributor.authorGursoy, P
dc.contributor.authorAtmaca, H
dc.contributor.authorKisim, A
dc.contributor.authorBozkurt, E
dc.contributor.authorUzunoglu, S
dc.contributor.authorSezgin, C
dc.contributor.authorSanli, UA
dc.contributor.authorKarabulut, B
dc.contributor.authorUslu, R
dc.contributor.authorKaraca, B
dc.date.accessioned2024-07-18T11:54:00Z
dc.date.available2024-07-18T11:54:00Z
dc.identifier.issn0732-183X
dc.identifier.other1527-7755
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/6052
dc.language.isoEnglish
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.titlePaclitaxel in combination with AT-101 induces apoptosis via supressing Bcl-2, bcl-XL, mcl-1 proteins in human breast cancer cells.
dc.typeMeeting Abstract

Files